The 51 references in paper M. Volkov M., A. Smirnov V., М. Волков М., А. Смирнов В. (2010) “РЕНТГЕНОЛОГИЧЕСКАЯ ОЦЕНКА КАЛЬЦИФИКАЦИИ БРЮШНОЙ АОРТЫ У БОЛЬНЫХ С ХРОНИЧЕСКОЙ БОЛЕЗНЬЮ ПОЧЕК, ПОЛУЧАЮЩИХ ГЕМОДИАЛИЗ: ЧАСТОТА ВЫЯВЛЕНИЯ И АССОЦИИРОВАННЫЕ ФАКТОРЫ // RADIOLOGICAL ASSESSMENT OF ABDOMINAL AORTIC CALCIFICATION IN PATIENTS WITH CHRONIC KIDNEY DISEASE RECEIVING HEMODIALYSIS: THE FREQUENCY OF DETECTION AND ASSOCIATED FACTORS” / spz:neicon:nefr:y:2010:i:3:p:37-45

1
Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998;32(5 Suppl 3):S112-119
(check this in PDF content)
2
Blacher J, Guerin AP, Pannier B et al. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 2001;38(4):938-942
(check this in PDF content)
3
London GM, Guerin AP, Marchais SJ et al. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 2003;18(9):1731-1740
(check this in PDF content)
4
Adragao T, Pires A, Lucas C et al. A simple vascular calcification score predicts cardiovascular risk in haemodialysis patients. Nephrol Dial Transplant 2004;19(6):1480-1488
(check this in PDF content)
5
Block GA, Raggi P, Bellasi A et al. Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients. Kidney Int 2007;71(5):438-441
(check this in PDF content)
6
Schlieper G, Kruger T, Djuric Z et al. Vascular access calcification predicts mortality in hemodialysis patients. Kidney Int 2008;74(12):1582-1587
(check this in PDF content)
7
Nitta K, Ogawa T. Aortic arch calcification and mortality in chronic hemodialysis patients. Rev Recent Clin Trials. 2010 May 11 [Epub ahead of print]
(check this in PDF content)
8
Iijima K, Hashimoto H, Hashimoto M et al. Aortic arch calcification detectable on chest X-ray is a strong independent predictor of cardiovascular events beyond traditional risk factors. Atherosclerosis. 2010; 210(1):137-144
(check this in PDF content)
9
Ogawa T, Ishida H, Akamatsu M et al. Progression of aortic arch calcification and all-cause and cardiovascular mortality in chronic hemodialysis patients. Int Urol Nephrol. 2010; 42(1):187-194.
(check this in PDF content)
10
Bellasi A, Raggi P Vascular calcification in patients with kidney disease. Techniques and technologies to assess vascular calcification. Seminars in Dialysis 2007; 20(2): 129-133
(check this in PDF content)
11
Adragao T, Frazao JM. Cardiovascular risk in dialysis patients: an X-ray vision on vascular calcifications. Kidney Int 2008;74(12):1505-1507
(check this in PDF content)
12
Wilson PW, Kauppila LI, O’Donnell CJ et al. Abdominal aortic calcific deposits are an important predictor of vascular morbidity and mortality. Circulation 2001; 103(11):1529-1534.
(check this in PDF content)
13
Kushiya F, Wada H, Sakakura M et al. Prognostic impact of aortic calcification index and ankle-arm blood pressure index in patients under hemodialysis. Clin Appl Thromb Hemost 2005;11(2):161-119
(check this in PDF content)
14
Bellasi A, Ferramosca E, Muntner P et al. Correlation of simple imaging tests and coronary artery calcium measured by computed tomography in hemodialysis patients. Kidney Int 2006; 70(9):1623-1628
(check this in PDF content)
15
Muntner P, Ferramosca E, Bellasi A et al. Development of a cardiovascular calcification index using simple imaging tools in haemodialysis patients. Nephrol Dial Transplant 2007; 22(2):508-514
(check this in PDF content)
16
Kauppila LI, Polak JF, Cupples LA et al. New indices to classify location, severity and progression of calcific lesions in the abdominal aorta: a 25-year follow-up study. Atherosclerosis 1997;132(2):245-250
(check this in PDF content)
17
Witteman JC, Grobbee DE, Valkenburg HA et al. J- shaped relation between change in diastolic blood pressure and progression of aortic atherosclerosis. Lancet 1994; 343(8896):504-507
(check this in PDF content)
18
Hak AE, Pols HA, van Hemert AM et al. Progression of aortic calcification is associated with metacarpal bone loss during menopause: a population-based longitudinal study. Arterioscler Thromb Vasc Biol 2000; 20(8):1926-1931
(check this in PDF content)
19
Taniwaki H, Ishimura E, Tabata T et al. Aortic calcification in haemodialysis patients with diabetes mellitus. Nephrol Dial Transplant 2005; 20(11):2472-2478
(check this in PDF content)
20
Ishimura E, Okuno S, Kitatani K et al. C-reactive protein is a significant predictor of vascular calcification of both aorta and hand arteries. Semin Nephrol 2004; 24(5):408-412
(check this in PDF content)
21
Kimura K, Saika X Otani H et al. Factors associated with calcification of the abdominal aorta in hemodialysis patients. Kidney Int Suppl 1999; 71:S238-241
(check this in PDF content)
22
Fabbian F, Catalano C, Orlandi V et al. Evaluation of aortic arch calcification in hemodialysis patients. J Nephrol 2005;18(3):289-293
(check this in PDF content)
23
Moe SM, Chen NX. Pathophysiology of vascular calcification in chronic kidney disease. Circ Res 2004; 95(6):560-567
(check this in PDF content)
24
Barnett E, Nordin BEC. The radiological diagnosisof osteoporosis. A new approach. Clin Radiol 1960; 11:166-174
(check this in PDF content)
25
Okuno S, Ishimura E, Kitatani K et al. Presence of abdominal aortic calcification is significantly associated with all-cause and cardiovascular mortality in maintenance hemodialysis patients. Am J Kidney Dis 2007; 49(3):417-425
(check this in PDF content)
26
Nakagawa K. A study of aortic calcification uremia. Nippon Jinzo Gakkai Shi 1997; 39(2):135-143
(check this in PDF content)
27
Rodriguez Garcia M, Gomez Alonso C, Naves Diaz M et al. Prevalence of vertebral fractures and aortic calcifications in hemodialysis patients: comparison with a population of the same age and sex. Nefrologia 2003;23 Suppl 2:106-111
(check this in PDF content)
28
Iribarren C, Sidney S, Sternfeld B, Browner WS. Calcification of the aortic arch: risk factors and association with coronary heart disease, stroke, and peripheral vascular disease. JAMA 2000; 283(21):2810-2815
(check this in PDF content)
29
Jayalath RW, Mangan SH, Golledge J. Aortic calcification. Eur J Vasc Endovasc Surg 2005;30(5):476-488
(check this in PDF content)
30
Kalantar-Zadeh K, Block G, Humphreys MH, Kopple JD. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int 2003; 63(3):793-808
(check this in PDF content)
31
Kovesdy CP, Anderson JE, Kalantar-Zadeh K. Inverse association between lipid levels and mortality in men with chronic kidney disease who are not yet on dialysis: effects of case mix and the malnutrition-inflammation-cachexia syndrome. J Am Soc Nephrol 2007; 18(1):304-311
(check this in PDF content)
32
Price PA, Roublick AM, Williamson MK. Artery calcification in uremic rats is increased by a low protein diet and prevented by treatment with ibandronate. Kidney Int 2006; 70(9):1577-1583
(check this in PDF content)
33
Kuhlmann MK, Levin NW. Potential interplay between nutrition and inflammation in dialysis patients. Contrib Nephrol 2008;161:76-82
(check this in PDF content)
34
Renard C, Van Obberghen E. Role of diabetes in atherosclerotic pathogenesis. What have we learned from animal models? Diabetes Metab 2006; 32(1):15-29
(check this in PDF content)
35
Yamada K, Fujimoto S, Nishiura R et al. Risk factors of the progression of abdominal aortic calcification in patients on chronic haemodialysis. Nephrol Dial Transplant 2007; 22(7): 2032-2037
(check this in PDF content)
36
Imanishi Y Kawata T, Kobayashi K et al. Vascular calcification in advanced secondary hyperparathyroidism. Clin Calcium 2005; 15 Suppl 1:110-112
(check this in PDF content)
37
Neves KR, Graciolli FG, dos Reis LM et al. Vascular calcification: contribution of parathyroid hormone in renal failure. Kidney Int 2007; 71(12):1262-1270
(check this in PDF content)
38
Joy MS, Karagiannis PC, Peyerl FW. Outcomes of secondary hyperparathyroidism in chronic kidney disease and the direct costs of treatment. J Manag Care Pharm 2007; 13(5):397-411
(check this in PDF content)
39
Rashid G, Bernheim J, Green J, Benchetrit S. Parathyroid hormone stimulates endothelial expression of atherosclerotic parameters through protein kinase pathways. Am J Physiol Renal Physiol 2007; 292(4):F1215-1218
(check this in PDF content)
40
Kostic S, Veljkovic S, Cekic S et al. The effect of parathormone on arterial blood pressure in patients on hemodialysis. Srp Arh Celok Lek 1996; 124 Suppl 1:115-116
(check this in PDF content)
41
Mathieu C, Adorini L. The coming of age of 1,25- dihydroxyvitamin D(3) analogs as immunomodulatory agents. Trends Mol Med 2002; 8(4):174-179
(check this in PDF content)
42
Kovesdy CP, Kalantar-Zadeh K. Vitamin D receptor activation and survival in chronic kidney disease. Kidney Int 2008; 73(12):1355-1363
(check this in PDF content)
43
Li YC, Kong J, Wei M et al. 1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 2002; 110:229-238
(check this in PDF content)
44
Linhartova K, Veselka J, Sterbakova G et al. Parathyroid hormone and vitamin D levels are independently associated with calcific aortic stenosis. Circ J 2008; 72(2):245-250
(check this in PDF content)
45
Добронравов ВА, Волков ММ, Мнускина ММ и др. Фосфорно-кальциевый баланс и минеральная плотность костей различных отделов скелета у больных на хроничес­ ком гемодиализе. Нефрология 2006; 10(4):31-36
(check this in PDF content)
46
Coen G, Manni M, Mantella D et al. Are PTH serum levels predictive of coronary calcifications in haemodialysis patients? Nephrol Dial Transplant 2007 ;22(11):3262-3267
(check this in PDF content)
47
Волков ММ, Смирнов АВ, Добронравов ВА и др. Кальциноз сердечных клапанов у пациентов с хронической болезнью почек: связь с клинико-биохимическими показа­ телями и влияние на внутрисердечную гемодинамику. Кли­ ническая медицина 2009; 87(6): 31-35
(check this in PDF content)
48
Ogawa T, Ishida H, Akamatsu M et al. Relation of oral 1alpha-hydroxy vitamin D3 to the progression of aortic arch calcification in hemodialysis patients. Heart Vessels 2010;25(1):1-6.
(check this in PDF content)
49
Mathew S, Lund RJ, Chaudhary LR et al. Vitamin D receptor activators can protect against vascular calcification. J Am Soc Nephrol 2008; 19(8):1509-1519
(check this in PDF content)
50
Teng M, Wolf M, Lowrie E et al. Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy. N Engl J Med 2003; 349(5):446-456
(check this in PDF content)
51
Shoji T, Shinohara K, Kimoto E et al. Lower risk for cardiovascular mortality in oral 1alpha-hydroxy vitamin D3 users in a haemodialysis population. Nephrol Dial Transplant 2004; 19(1):179-184 Поступила в редакцию 15.07.2010 г.
(check this in PDF content)